SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-011622
Filing Date
2017-11-09
Accepted
2017-11-09 08:12:07
Documents
3
Period of Report
2017-11-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k110817_therapixbio.htm 6-K 17328
2 PRESS RELEASE DATED NOVEMBER 9, 2017 f6k110817ex99-1_therapix.htm EX-99.1 234021
3 GRAPHIC ex99i_01.jpg GRAPHIC 38851
  Complete submission text file 0001213900-17-011622.txt   306059
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 171188344
SIC: 2834 Pharmaceutical Preparations